149 related articles for article (PubMed ID: 14770077)
1. Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update.
Ruuskanen O
Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S135-9. PubMed ID: 14770077
[TBL] [Abstract][Full Text] [Related]
2. [Use of azithromycin in the treatment of acute otitis media and tonsillopharyngitis: summary and conclusions.
Klein JO; Schaad UB
Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S140-1. PubMed ID: 14770078
[No Abstract] [Full Text] [Related]
3. Rationale for single and high dose treatment regimens with azithromycin.
Gordon EM; Blumer JL
Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S102-7. PubMed ID: 14770072
[TBL] [Abstract][Full Text] [Related]
4. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.
Block SL; Cifaldi M; Gu Y; Paris MM
Clin Ther; 2005 Jun; 27(6):786-94. PubMed ID: 16117986
[TBL] [Abstract][Full Text] [Related]
5. The comparison of single-dose ceftriaxone, five-day azithromycin, and ten-day amoxicillin/clavulanate for the treatment of children with acute otitis media.
Biner B; Celtik C; Oner N; Küçükuğurluoğlu Y; Güzel A; Yildirim C; Adali MK
Turk J Pediatr; 2007; 49(4):390-6. PubMed ID: 18246740
[TBL] [Abstract][Full Text] [Related]
6. Single dose azithromycin for the treatment of uncomplicated otitis media.
Arguedas A; Loaiza C; Soley C
Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S108-14. PubMed ID: 14770073
[TBL] [Abstract][Full Text] [Related]
7. Single-dose azithromycin for respiratory tract infections.
Law C; Amsden GW
Ann Pharmacother; 2004 Mar; 38(3):433-9. PubMed ID: 14970367
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of North American ginseng extract in the treatment of pediatric upper respiratory tract infection: a phase II randomized, controlled trial of 2 dosing schedules.
Vohra S; Johnston BC; Laycock KL; Midodzi WK; Dhunnoo I; Harris E; Baydala L
Pediatrics; 2008 Aug; 122(2):e402-10. PubMed ID: 18676527
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.
Dunne MW; Latiolais T; Lewis B; Pistorius B; Bottenfield G; Moore WH; Garrett A; Stewart TD; Aoki J; Spiegel C; Boettger D; Shemer A
J Antimicrob Chemother; 2003 Sep; 52(3):469-72. PubMed ID: 12888586
[TBL] [Abstract][Full Text] [Related]
10. Single-dose azithromycin for the treatment of children with acute otitis media.
Soley CA; Arguedas A
Expert Rev Anti Infect Ther; 2005 Oct; 3(5):707-17. PubMed ID: 16207162
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the clinical efficacy of azithromycin in acute respiratory infections in children].
Bottaro G; Rotolo N; Bonforte S; Bucchieri R; De Luca P; Ficarra G; Gulino A; Melillo P; Nicosia A; Prestifilippo F
Clin Ter; 1994 Jul; 145(7):35-9. PubMed ID: 7955949
[TBL] [Abstract][Full Text] [Related]
12. Otitis media and sinusitis: similar diseases.
Parsons DS; Wald ER
Otolaryngol Clin North Am; 1996 Feb; 29(1):11-25. PubMed ID: 8834269
[TBL] [Abstract][Full Text] [Related]
13. Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial.
Cascio A; Colomba C; Antinori S; Paterson DL; Titone L
Clin Infect Dis; 2002 Jan; 34(2):154-8. PubMed ID: 11740701
[TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of azithromycin in the treatment of respiratory infections in children.
Lakoš AK; Pangerčić A; Gašparić M; Kukuruzović MM; Kovačić D; Baršić B
Curr Med Res Opin; 2012 Jan; 28(1):155-62. PubMed ID: 22070514
[TBL] [Abstract][Full Text] [Related]
15. Age inconsistency in the American Academy of Pediatrics guidelines for acute otitis media.
Meropol SB; Glick HA; Asch DA
Pediatrics; 2008 Apr; 121(4):657-68. PubMed ID: 18381528
[TBL] [Abstract][Full Text] [Related]
16. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis.
Casey JR; Pichichero ME
Clin Infect Dis; 2005 Jun; 40(12):1748-55. PubMed ID: 15909262
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin: 3-day versus 5-day course in the treatment of respiratory tract infections in children. Croatian Azithromycin Study Group.
Ficnar B; Huzjak N; Oreskovic K; Matrapazovski M; Klinar I
J Chemother; 1997 Feb; 9(1):38-43. PubMed ID: 9106016
[TBL] [Abstract][Full Text] [Related]
18. Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin.
Arnez M; Pleterski-Rigler D; Luznik-Bufon T; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):498-504. PubMed ID: 12422590
[TBL] [Abstract][Full Text] [Related]
19. Azithromycin pulses in the treatment of inflammatory and pustular acne: efficacy, tolerability and safety.
Antonio JR; Pegas JR; Cestari TF; Do Nascimento LV
J Dermatolog Treat; 2008; 19(4):210-5. PubMed ID: 18608737
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of 3-day, once-daily azithromycin suspension versus standard treatments for community-acquired paediatric infectious diseases.
Treadway G; Reisman A
Int J Antimicrob Agents; 2001 Nov; 18(5):427-31. PubMed ID: 11711256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]